NEW YORK — Pfizer Inc. said Friday it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage.
Pfizer pulls Thelin off the market
Friday, December 10, 2010 | 10:36 a.m. CST
To read the full article, please sign up or login.
Get full access to the Columbia Missourian on your computer, phone, and tablet for just $5.95 per month. Or click here for full access for one day for only 99 cents.
* Unlimited access on your iPhone, iPad, Android phone and Android tablet
* All the high-quality, in-depth journalism of the Columbia Missourian and Vox Magazine, updated 24/7
* Your news. Your device. Your time.
If you'd like to read more about the value of being a member, read this column from the Missourian's executive editor, Tom Warhover.
advertisements
